Parametric Portfolio Associates’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$3.02M Sell
77,774
-13,819
-15% -$535K ﹤0.01% 2182
2021
Q4
$5.36M Buy
91,593
+5,105
+6% +$289K ﹤0.01% 1812
2021
Q3
$5.13M Sell
86,488
-4,199
-5% -$329K ﹤0.01% 1810
2021
Q2
$7.87M Buy
90,687
+5,910
+7% +$476K ﹤0.01% 1555
2021
Q1
$6.99M Buy
84,777
+6,037
+8% +$578K ﹤0.01% 1935
2020
Q4
$7.16M Buy
78,740
+17,450
+28% +$1.08M ﹤0.01% 1836
2020
Q3
$2.45M Buy
61,290
+3,962
+7% +$138K ﹤0.01% 2383
2020
Q2
$1.97M Sell
57,328
-3,484
-6% -$104K ﹤0.01% 2513
2020
Q1
$1.35M Buy
60,812
+38,572
+173% +$975K ﹤0.01% 2615
2019
Q4
$435K Buy
22,240
+2,130
+11% +$33.8K ﹤0.01% 3418
2019
Q3
$312K Buy
20,110
+2,847
+16% +$54.6K ﹤0.01% 3510
2019
Q2
$350K Buy
17,263
+2,763
+19% +$49.8K ﹤0.01% 3516
2019
Q1
$255K Sell
14,500
-386
-3% -$6.09K ﹤0.01% 3622
2018
Q4
$191K Buy
14,886
+2,697
+22% +$37.6K ﹤0.01% 3672
2018
Q3
$199K Sell
12,189
-1,384
-10% -$16.4K ﹤0.01% 3765
2018
Q2
$154K Sell
13,573
-81,581
-86% -$899K ﹤0.01% 3749
2018
Q1
$929K Buy
95,154
+83,120
+691% +$796K ﹤0.01% 3060
2017
Q4
$74K Buy
+12,034
New +$53.7K ﹤0.01% 3848

Other funds holding FATE